Connect with:
Monday / December 9. 2024
HomeAgribusinessIIL delivers 34% growth in Net Profit in H1 FY25

IIL delivers 34% growth in Net Profit in H1 FY25

IIL has witnessed a growth in premium products by 11 per cent, with Focus Maharatna and Maharatna now constituting 68 per cent of total B2C sales in Q2 FY25, up from 65 per cent in Q2 FY24

Insecticides (India) Limited, one of India’s leading crop protection and nutrition company, announced its financial results for the quarter and half year ended September 30, 2024.

Q2 FY25 and H1 FY25 – Consolidated Financial Performance                  

Particulars (Rs. in Crs)Q2 FY25Q2 FY24Y-o-YH1 FY25H1 FY24Y-o-Y
Revenue from Operations627696-10%1,2841,336-4%
EBITDA90829%16112826%
EBITDA Margin (%)14.3%11.8%12.5%9.6%
Profit After Tax615316%1118234%
PAT Margin (%)9.8%7.6%8.6%6.2%
Insecticides (India) Ltd. (IIL) is one of India’s leading crop protection and Nutrition company. IIL boasts of an impressive product portfolio consisting of 20+ technical products and 125+ formulation products. With its iconic “TRACTOR BRAND” products, a trusted choice among farmers nationwide, IIL has fostered a strong and enduring bond with the farming community. The company is fully integrated with two technical synthesis plants, six formulation plants(including one EOU), and a biological plant under a toll arrangement, allowing for seamless operations across R&D, technical synthesis, formulation, and comprehensive marketing & extension activities. Tie-ups & Collaborations with international research giants like OAT Agrio Co. Ltd., Japan and Nissan Chemical Corporation, Japan, alongside four R&D centers (including a GLP-certified research facility in Chopanki), showcase our commitment to bring the latest international technology for the farmers. IIL foundation, an initiative by IIL, is involved in imparting knowledge to farmers regarding modern agricultural practices to improve their crop productivity. IIL has connect with 21,00,000+ farmers, 70,000+ dealers, 7,500+distributors. IIL prides of having great R&D capabilities and technical expertise to provide farmers with effective and innovative products.

IIL registered 7 per cent growth in B2C revenue, despite macro industry headwinds with unpredictable weather pattern particularly excessive & continued rain which delayed spraying season, impacting the overall growth in Q2FY25. Gross profit margins improved by 670 bps to 32% with focus on premium products and effective cost management on procurement side. The organization has exhibited continuous robust performance in premium products through New Product Launches, aggressive marketing activities and educating farmers with newer technologies.

Commenting on the results and performance, Rajesh Aggarwal,MD of Insecticides (India) Ltd. said: “We are pleased to announce our Q2 & H1 FY25 results, reflecting healthy performance across key financial and operational metrics. Achieving Net Profit of Rs 111 Crs in the first half, we have already surpassed the full FY24 profit of Rs 102 Crs—a testament to the strength of our strategy and execution. Our focus will remain on driving higher growth in premium products, underpinned by New Product Launches, more extensive demand generation and brand-building initiatives.

This quarter, the team has launched an innovative 9(3) herbicide for maize, Torry Super based on SPF technology, developed by in-house R&D team. SPF technology of Torry Super will provide faster results and long duration control of weeds. The pilot experiments are getting an overwhelming response of the Torry Superin maize of Rabi season in the southern & western part of the country, where the season has already begun. The Strategic emphasis remains on premiumization, capital efficiency and surplus cash generation with visible improvement across profitability, working capital & ROCE, ROE.

In a move to reward the shareholders, IIL completed a buyback of 500,000 fully paid-up equity shares at Rs 1,000 each, amounting to Rs 50 Crs, through internal accrual. With favorable market conditions and intense focus on premiumization, IIL expects healthy profit growth and leaner balance sheet as IIL progresses into this financial year.“

Share

No comments

leave a comment